Emergen logo.png
Radiofrequency Ablation Devices market Size Worth USD 13.20 Billion in 2032 | Emergen Research
04. Januar 2024 07:44 ET | Emergen Research
Vancouver, Jan. 04, 2024 (GLOBE NEWSWIRE) -- The global Radiofrequency Ablation (RFA) devices market size was USD 4.30 Billion in 2022 and is expected to register a rapid revenue CAGR of 12.0%...
Logo.jpg
Celsion Announces Enrollment Completion for Pivotal Phase III OPTIMA Study of ThermoDox® in Primary Liver Cancer
05. September 2018 08:00 ET | Celsion CORP
 550 Patient Study Designed to Determine if ThermoDox® Can Significantly Prolong the Lives of Patients with Liver Cancer OPTIMA Study’s Hypothesis Independently Confirmed by the National Institutes...